# Schizophrenia research and treatment

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/schizophrenia-research-and-treatment/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the research, treatment, and various aspects of schizophrenia, including the effectiveness of antipsychotic drugs, neurocognitive deficits, genetic association studies, metabolic syndrome, neurodevelopmental models, cognitive therapy, social cognition, prodromal symptoms, dopamine dysfunction, and neuroanatomical abnormalities in individuals with schizophrenia. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10023 |
| Works | 686 |

## Topic papers all

Showing 15 of 686.

- [Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia](https://scholariq.org/papers/effectiveness-of-antipsychotic-drugs-in-patients-with-chronic-schizophrenia/)
- [Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-tolerability-of-15-antipsychotic-drugs-in-schizophrenia/)
- [Prevalence of mental disorders in China: a cross-sectional epidemiological study](https://scholariq.org/papers/prevalence-of-mental-disorders-in-china-a-cross-sectional-epidemiological-study/)
- [Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis](https://scholariq.org/papers/antipsychotic-induced-weight-gain-a-comprehensive-research-synthesis/)
- [A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-psychosis-continuum-evidence-for-a/)
- [Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study](https://scholariq.org/papers/common-genetic-determinants-of-schizophrenia-and-bipolar-disorder-in-swedish/)
- [Schizophrenia](https://scholariq.org/papers/schizophrenia/)
- [Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample](https://scholariq.org/papers/using-the-strengths-and-difficulties-questionnaire-sdq-to-screen-for-child/)
- [Prevalence and determinants of common perinatal mental disorders in women in low- and lower-middle-income countries: a systematic review](https://scholariq.org/papers/prevalence-and-determinants-of-common-perinatal-mental-disorders-in-women-in-low/)
- [Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder](https://scholariq.org/papers/canadian-network-for-mood-and-anxiety-treatments-scp-canmat-scp-and/)
- [Neurobiology of emotion perception II: implications for major psychiatric disorders](https://scholariq.org/papers/neurobiology-of-emotion-perception-ii-implications-for-major-psychiatric/)
- [Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-epidemiology-and-burden-of-schizophrenia-findings-from-the-global-burden/)
- [Genome-wide association analysis identifies 13 new risk loci for schizophrenia](https://scholariq.org/papers/genome-wide-association-analysis-identifies-13-new-risk-loci-for-schizophrenia/)
- [The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness](https://scholariq.org/papers/the-lancet-psychiatry-commission-a-blueprint-for-protecting-physical-health-in/)
- [Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population](https://scholariq.org/papers/lifetime-prevalence-of-psychotic-and-bipolar-i-disorders-in-a-general-population/)

## Topic primary papers

Showing 15 of 295.

- [Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia](https://scholariq.org/papers/effectiveness-of-antipsychotic-drugs-in-patients-with-chronic-schizophrenia/)
- [Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis](https://scholariq.org/papers/comparative-efficacy-and-tolerability-of-15-antipsychotic-drugs-in-schizophrenia/)
- [Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis](https://scholariq.org/papers/antipsychotic-induced-weight-gain-a-comprehensive-research-synthesis/)
- [A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-psychosis-continuum-evidence-for-a/)
- [Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study](https://scholariq.org/papers/common-genetic-determinants-of-schizophrenia-and-bipolar-disorder-in-swedish/)
- [Schizophrenia](https://scholariq.org/papers/schizophrenia/)
- [Neurobiology of emotion perception II: implications for major psychiatric disorders](https://scholariq.org/papers/neurobiology-of-emotion-perception-ii-implications-for-major-psychiatric/)
- [Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016](https://scholariq.org/papers/global-epidemiology-and-burden-of-schizophrenia-findings-from-the-global-burden/)
- [Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population](https://scholariq.org/papers/lifetime-prevalence-of-psychotic-and-bipolar-i-disorders-in-a-general-population/)
- [The Psychosis High-Risk State](https://scholariq.org/papers/the-psychosis-high-risk-state/)
- [Predicting Psychosis](https://scholariq.org/papers/predicting-psychosis/)
- [11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)](https://scholariq.org/papers/11-year-follow-up-of-mortality-in-patients-with-schizophrenia-a-population-based/)
- [Psychiatric Comorbidities and Schizophrenia](https://scholariq.org/papers/psychiatric-comorbidities-and-schizophrenia/)
- [Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology](https://scholariq.org/papers/treatment-resistant-schizophrenia-treatment-response-and-resistance-in-psychosis/)
- [Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium](https://scholariq.org/papers/cortical-brain-abnormalities-in-4474-individuals-with-schizophrenia-and-5098/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.